Delivery Order SPE2DB20D3304-SPE2DB24FW7L3

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,627.55 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 1,000 units of the drug Tamsulosin HCL 0.4 mg capsules. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to...
This is a $22,113.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the supply of 1,000 units of the generic medication Tamsulosin HCl 0.4 mg capsules. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This $2,888.08 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,910 units of the prescription drug Tamsulosin HCl 0.4 mg capsules. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which enables the federal government to efficiently procure a wide range of essential pharmaceutical and medical...
This is a $4,194.81 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 1,000 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of Tamsulosin Hydrochloride 0.4 mg capsules. The contract has a ceiling value of $2,893.72 and runs through April 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of 1,000 units of the drug Tamsulosin Hydrochloride 0.4 mg capsules. The contract has a firm fixed price of $1,791.90 and a period of performance through March 26, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to...
This is a $1,039.21 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of 4,567,202,696 units of the generic drug Tamsulosin HCL 0.4 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for 1,000 units of the prescription drug Tamsulosin HCL 0.4 mg capsules. The contract has a ceiling value of $1,100.87 and a completion date of March 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,352,432 units of Tamsulosin Hydrochloride 0.4 mg capsules. The contract has a ceiling value of $2,486.38 and a completion date of November 7, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a $1,006.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is to supply 4,567,291,029 units of the generic drug Tamsulosin HCL 0.4 mg capsules. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB24FW7L3
    Delivery Order

This is a $12,920.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 1,000 units of the pharmaceutical product Tamsulosin HCl 0.4 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, that enables the government to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and the ultimate completion date is September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense and civilian agencies to provide essential medical supplies and prescription drugs.

Generated 12/24/24, 9:22 AM